Ontology highlight
ABSTRACT: Introduction
Cancer-related cognitive impairment (CRCI) can have detrimental effects on quality of life, even among patients with non-central nervous system (CNS) cancers. Several studies have been conducted to explore different markers associated with CRCI to understand its pathobiology. It is proposed that the underlying mechanisms of CRCI are related to a cascade of physiological adaptive events in response to cancer and/or treatment. Hence, peripheral blood would be a logical source to observe and identify these physiological events. This paper outlines the protocol for a scoping review being conducted to summarise the extant literature regarding blood-based biomarkers of CRCI among patients with non-CNS cancer.Methods/analysis
Methods will be informed by the updated gu
SUBMITTER: Mayo SJ
PROVIDER: S-EPMC5829658 | biostudies-literature | 2018 Jan
REPOSITORIES: biostudies-literature